CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Shares withheld for taxes President & CEO gave up 2,015 shares (to pay taxes)
- 4 Grant or award Chief Medical Officer acquired 8,084 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 7,920 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 3,859 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 11,674 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 1,500,000 shares at $7.54 ($11,310,000)
- 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 1,303,636 shares at an average $8.74 ($11,395,493)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 200,000 shares at an average $4.79 ($957,100)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 13 of 34 · 674 filings